%0 Journal Article %T Duloxetine for AI-associated joint pain in breast cancer patients %A Tsuda, Moe %A Toi, Masakazu %J Translational Cancer Research %D 2018 %B 2018 %9 %! Duloxetine for AI-associated joint pain in breast cancer patients %K %X Aromatase inhibitors (AIs) are the standard of care for treatment of both early and advanced hormone-sensitive breast cancer in postmenopausal women. Although AIs have been considered to be well-tolerated, only 50 % of patients can complete the full course of the treatment, at the optimal schedule (1). %U https://tcr.amegroups.org/article/view/20388 %P S480-S483 %@ 2219-6803